Harmonicare Medical Holdings Limited announced audited consolidated earnings results for the year ended December 31, 2017. For the full year, the company reported revenue was RMB 924,151,000 against RMB 859,701,000 a year ago. Profit before tax was RMB 33,947,000 against RMB 123,886,000 a year ago. Profit for the year was RMB 29,438,000 against RMB 97,271,000 a year ago. Profit for the year attributable to owners of the company was RMB 27,394,000 against RMB 95,708,000 a year ago. Basic and diluted earnings per share were 3.61 cents against 12.53 cents a year ago. Net cash generated from operating activities was RMB 18,694,000 against RMB 105,892,000 a year ago. The amount of capital expenditures of the Group was approximately RMB 121.13 million for the Review Period, representing an increase of RMB 70.82 million as compared with that of the Corresponding Period. During the Review Period, capital expenditures principal y included: purchase of fixed assets, expenses for construction- in-progress of hospitals of approximately RMB 119.94 million; and expenses for purchase of software system of approximately RMB 1.19 million.